Prevention and management of arm lymphedema in the patient with breast cancer.
Identifieur interne : 003876 ( PubMed/Curation ); précédent : 003875; suivant : 003877Prevention and management of arm lymphedema in the patient with breast cancer.
Auteurs : Mehra Golshan [États-Unis] ; Barbara SmithSource :
- The journal of supportive oncology [ 1544-6794 ] ; 2006.
Descripteurs français
- KwdFr :
- MESH :
- étiologie : Lymphoedème.
- Bras, Femelle, Humains, Lymphoedème, Soins palliatifs, Tumeurs du sein.
English descriptors
- KwdEn :
- MESH :
- complications : Breast Neoplasms.
- etiology : Lymphedema.
- methods : Palliative Care.
- prevention & control : Lymphedema.
- therapy : Lymphedema.
- Arm, Female, Humans.
Abstract
Arm lymphedema develops in 10%-35% of patients who undergo axillary dissection and/or nodal radiation therapy for breast cancer. Lymphedema that occurs in the first 18 months after surgery or radiation is described as acute lymphedema, and can be managed with conservative measures such as elevation of the arm and mild compression. Chronic lymphedema, the more serious form, has a progressive and generally irreversible course. Risk factors associated with the development of lymphedema include greater extent of axillary surgery; more positive axillary nodes; a postoperative axillary hematoma, seroma, or infection; and use of nodal radiation. The most common method of lymphedema measurement is the circumference 10 cm above and below the olecranon process, although most clinicians do not take measurements in the preoperative setting for comparison.Treatment strategies include elevation, complete decongestive physiotherapy, pneumatic pumps, and, after failure of all other methods, surgery. Lymphangiosarcoma is a rare and late complication of longstanding extremity lymphedema. The advent of sentinel lymph node biopsy as an alternative to axillary dissection should decrease the rate of lymphedema. The increasing number of breast cancer survivors and the high prevalence of the disease will continue to make lymphedema a significant consequence of breast cancer treatment.
PubMed: 17004511
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003876
Links to Exploration step
pubmed:17004511Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prevention and management of arm lymphedema in the patient with breast cancer.</title><author><name sortKey="Golshan, Mehra" sort="Golshan, Mehra" uniqKey="Golshan M" first="Mehra" last="Golshan">Mehra Golshan</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, Brigham and Women's Hospital and the Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA. mgolshan@partners.org</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Surgery, Brigham and Women's Hospital and the Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115</wicri:regionArea></affiliation></author><author><name sortKey="Smith, Barbara" sort="Smith, Barbara" uniqKey="Smith B" first="Barbara" last="Smith">Barbara Smith</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2006">2006</date><idno type="RBID">pubmed:17004511</idno><idno type="pmid">17004511</idno><idno type="wicri:Area/PubMed/Corpus">003876</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003876</idno><idno type="wicri:Area/PubMed/Curation">003876</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003876</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Prevention and management of arm lymphedema in the patient with breast cancer.</title><author><name sortKey="Golshan, Mehra" sort="Golshan, Mehra" uniqKey="Golshan M" first="Mehra" last="Golshan">Mehra Golshan</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, Brigham and Women's Hospital and the Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA. mgolshan@partners.org</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Surgery, Brigham and Women's Hospital and the Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115</wicri:regionArea></affiliation></author><author><name sortKey="Smith, Barbara" sort="Smith, Barbara" uniqKey="Smith B" first="Barbara" last="Smith">Barbara Smith</name></author></analytic><series><title level="j">The journal of supportive oncology</title><idno type="ISSN">1544-6794</idno><imprint><date when="2006" type="published">2006</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Arm</term><term>Breast Neoplasms (complications)</term><term>Female</term><term>Humans</term><term>Lymphedema (etiology)</term><term>Lymphedema (prevention & control)</term><term>Lymphedema (therapy)</term><term>Palliative Care (methods)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Bras</term><term>Femelle</term><term>Humains</term><term>Lymphoedème ()</term><term>Lymphoedème (étiologie)</term><term>Soins palliatifs ()</term><term>Tumeurs du sein ()</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Palliative Care</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Arm</term><term>Female</term><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Bras</term><term>Femelle</term><term>Humains</term><term>Lymphoedème</term><term>Soins palliatifs</term><term>Tumeurs du sein</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Arm lymphedema develops in 10%-35% of patients who undergo axillary dissection and/or nodal radiation therapy for breast cancer. Lymphedema that occurs in the first 18 months after surgery or radiation is described as acute lymphedema, and can be managed with conservative measures such as elevation of the arm and mild compression. Chronic lymphedema, the more serious form, has a progressive and generally irreversible course. Risk factors associated with the development of lymphedema include greater extent of axillary surgery; more positive axillary nodes; a postoperative axillary hematoma, seroma, or infection; and use of nodal radiation. The most common method of lymphedema measurement is the circumference 10 cm above and below the olecranon process, although most clinicians do not take measurements in the preoperative setting for comparison.Treatment strategies include elevation, complete decongestive physiotherapy, pneumatic pumps, and, after failure of all other methods, surgery. Lymphangiosarcoma is a rare and late complication of longstanding extremity lymphedema. The advent of sentinel lymph node biopsy as an alternative to axillary dissection should decrease the rate of lymphedema. The increasing number of breast cancer survivors and the high prevalence of the disease will continue to make lymphedema a significant consequence of breast cancer treatment.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17004511</PMID><DateCreated><Year>2006</Year><Month>09</Month><Day>28</Day></DateCreated><DateCompleted><Year>2006</Year><Month>12</Month><Day>14</Day></DateCompleted><DateRevised><Year>2009</Year><Month>11</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1544-6794</ISSN><JournalIssue CitedMedium="Print"><Volume>4</Volume><Issue>8</Issue><PubDate><Year>2006</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The journal of supportive oncology</Title><ISOAbbreviation>J Support Oncol</ISOAbbreviation></Journal><ArticleTitle>Prevention and management of arm lymphedema in the patient with breast cancer.</ArticleTitle><Pagination><MedlinePgn>381-6</MedlinePgn></Pagination><Abstract><AbstractText>Arm lymphedema develops in 10%-35% of patients who undergo axillary dissection and/or nodal radiation therapy for breast cancer. Lymphedema that occurs in the first 18 months after surgery or radiation is described as acute lymphedema, and can be managed with conservative measures such as elevation of the arm and mild compression. Chronic lymphedema, the more serious form, has a progressive and generally irreversible course. Risk factors associated with the development of lymphedema include greater extent of axillary surgery; more positive axillary nodes; a postoperative axillary hematoma, seroma, or infection; and use of nodal radiation. The most common method of lymphedema measurement is the circumference 10 cm above and below the olecranon process, although most clinicians do not take measurements in the preoperative setting for comparison.Treatment strategies include elevation, complete decongestive physiotherapy, pneumatic pumps, and, after failure of all other methods, surgery. Lymphangiosarcoma is a rare and late complication of longstanding extremity lymphedema. The advent of sentinel lymph node biopsy as an alternative to axillary dissection should decrease the rate of lymphedema. The increasing number of breast cancer survivors and the high prevalence of the disease will continue to make lymphedema a significant consequence of breast cancer treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Golshan</LastName><ForeName>Mehra</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Brigham and Women's Hospital and the Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA. mgolshan@partners.org</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Barbara</ForeName><Initials>B</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Support Oncol</MedlineTA><NlmUniqueID>101181305</NlmUniqueID><ISSNLinking>1544-6794</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Support Oncol. 2006 Sep;4(8):389-90</RefSource><PMID Version="1">17004512</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Support Oncol. 2006 Sep;4(8):392-3</RefSource><PMID Version="1">17004513</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001132" MajorTopicYN="N">Arm</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010166" MajorTopicYN="N">Palliative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>57</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>9</Month><Day>29</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>12</Month><Day>15</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>9</Month><Day>29</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17004511</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003876 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 003876 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:17004511
|texte= Prevention and management of arm lymphedema in the patient with breast cancer.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:17004511" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |